Sitamepo Tablets 50/1000 mg
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
MFDS item code 202200200 · Approved 2022.01.11
Improvement of blood sugar control in type 2 diabetes
This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It is used when blood sugar control is difficult with diet alone or when alone it is insufficient with metformin or sitagliptin. It can also be used in combination with other diabetes medications such as metformin, sulfonylureas, thiazolidinediones, and insulin to effectively manage blood sugar when control is insufficient. It aids in improving blood sugar control by supplementing or replacing various treatment methods. For these reasons, this medication is used to improve blood sugar control in patients with type 2 diabetes.
This medication is generally taken twice daily with food, and the dosage may be gradually increased to reduce gastrointestinal adverse reactions associated with metformin. 1. In patients not currently receiving treatment with metformin: Take this medication 50/500 mg twice daily, one tablet per dose, and it can be increased to 50/1000 mg, one tablet twice daily. 2. In patients undergoing treatment with metformin:
This medication contains sitagliptin and metformin and is primarily used for blood sugar control in patients with type 2 diabetes. When taking this medication, severe allergic reactions may occur, so if symptoms like skin rash, hives, or difficulty breathing develop, discontinue use immediately and consult a doctor. Serious side effects such as acute pancreatitis, which is inflammation of the pancreas, have been reported, so if symptoms like abdominal pain, nausea, or vomiting occur, seek medical attention promptly. Metformin can rarely cause a metabolic disorder known as lactic acidosis, which can be fatal, so if symptoms like difficulty breathing, muscle pain, fatigue, or abdominal pain occur during use, inform a doctor immediately. Patients with poor kidney function or conditions such as severe infection, dehydration, acute myocardial infarction, or acute heart failure should not use this medication. The use of this medication should be temporarily halted if planned for surgery or radiological contrast examinations, resuming only after confirming normal kidney function. Pregnant women, women of childbearing potential, and nursing mothers should not take this medication. This medication carries a risk of hypoglycemia, so caution is needed when irregular meals or vigorous exercise occur, or when taken with other hypoglycemic agents. During treatment, it is recommended to regularly check kidney function and blood tests, and also to monitor for vitamin B12 deficiency. Alcohol can increase the risk of side effects from this medication, hence excessive drinking should be avoided during treatment. If severe joint pain or blisters on the skin occur during treatment, inform a doctor immediately. In case of overdose, immediate medical treatment is necessary, and sitagliptin can be partially removed by hemodialysis. Patients taking this medication should fully understand its effects and side effects, consistently take it as directed by their doctor, and undergo regular check-ups.
Hives, hypersensitivity reactions (anaphylaxis, angioedema), exfoliative skin diseases (Stevens-Johnson syndrome), pancreatitis (including acute pancreatitis), acute renal failure, difficulty breathing, severe joint pain with disability, bullous pemphigoid, thrombocytopenia, elevated liver enzymes, acute renal failure, difficulty breathing, unstable angina, severe allergic reactions (anaphylaxis, angioedema), severe skin adverse reactions (rash, hives, bullous pemphigoid)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.
Pink oval film-coated tablet
30 tablets/box[(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 858.5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 505mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 505mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 858.5mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Samsung Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride with Colloidal Anhydrous Silica 1010mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.